摘要
本文从跨国制药企业的并购现象出发,以知识产权视角分析了辉瑞并购惠氏的行为,并通过对比分析全球三大生物制药公司(安进、基因泰克、惠氏)的中国区专利申请情况,藉此解析辉瑞并购惠氏背后的知识产权因素和制药业未来的市场竞争热点,以及并购行为对国内制药企业的可能影响。
According to the mergers and acquisitions of multinational pharmaceutical companies,Pfizer’s purchase of Wyeth is analyzed from the perspective of the intellectual property rights in this paper.The patent applications into China of three global famous bio-technology companies（Amgen,Genetech and Wyeth） are compared,targeting to resolve the intellectual property rights driving forces for Pfizer’s purchase of Wyeth and the market competition hotspots between pharmaceutical companies in future,and provide suggestions for Chinese domestic corporations
出处
《食品与药品》
CAS
2011年第3期77-82,共6页
Food and Drug
关键词
并购:知识产权
跨国制药公司
生物
专利
mergers and acquisitions
intellectual property rights
multinational pharmaceutical companies
biotechnology
patent
